TDAY compared with ABUS: revenue, margins and what each company keeps, and the suppliers and customers both name

TDAYUSA TODAY Co., Inc.

Mkt capRevenueRevenue

ABUSArbutus Biopharma Corp

Mkt capRevenueRevenue

Compare

TDAYUSA TODAY Co., Inc.

ABUSArbutus Biopharma Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

TDAY

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±8.6%▼−7.62%×0.88

Q1 FY26±12.2%▼−0.69%×0.06

Feb 26 '26±14.3%▲+4.58%×0.32

Q3 FY25—▲+27.74%—

ABUS

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26—▼−1.71%—

May 13 '26±6.5%0.00%×0.00

= impliedTDAY realized, solidABUS realized, hatchedOne scale, both sides: full bar = 28%× = |realized| ÷ impliedSource: market data

Q1 FY26

±13.7%

▲+4.25%

×0.31

Q3 FY25±22.5%▼−5.79%×0.26

TDAYUSA TODAY Co., Inc.

6.18▼−0.16%· post 6.18

Mkt cap$907.3MRevenue$536MQ2 FY26Revenue$2.3BFY25

ABUSArbutus Biopharma Corp

4.20▼−1.82%· post 4.20

ClosedOct 30 '26

Mkt cap$832.9MRevenue$1MQ2 FY26Revenue$14MFY25

Compare

ClosedOct 30 '26

TDAYUSA TODAY Co., Inc.

ABUSArbutus Biopharma Corp

6.18▼−0.16%post 6.18

Price

4.20▼−1.82%post 4.20

$907.3M

Mkt cap

$832.9M

Q2 FY26$536M

Revenue

$1MQ2 FY26

FY25$2.3B

Revenue

$14MFY25

TDAY6.18▼−0.16%vsABUS4.20▼−1.82%ClosedOct 30 '26